Home › Companies › LEXICON PHARMACEUTICALS INC. › 2024-2025
At LEXICON PHARMACEUTICALS INC.'s shareholder meeting held June 2, 2025, in the 2024-2025 proxy season, 96 asset managers reported how they voted in their SEC Form N-PX filings, covering 709 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LEXICON PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed June 3, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 2, 2025: 7 items on LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed June 3, 2025: 7 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore LEXICON PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LEXICON PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Raymond Debbane | 205,200,038 | -- | -- | 24,376,510 | 51,246,117 | 89% | Not verified | — |
| Elect Director: Ivan H. Cheung | 226,232,365 | -- | -- | 3,344,183 | 51,246,117 | 99% | Not verified | — |
| 2. Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan | 217,050,897 | 10,939,106 | 1,586,545 | -- | 51,246,117 | 95% | Not verified | — |
| 3. Ratification and approval of the amendment to the Company's 2017 Non-Employee Directors' Equity Incentive Plan | 220,279,044 | 8,172,361 | 1,125,143 | -- | 51,246,117 | 96% | Not verified | — |
| 4. Approval of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's board of directors, a reverse split of its common stock, at a ratio within a range of 1-for-10 to 1-for-50, at an | 252,035,936 | 28,448,014 | 338,715 | -- | -- | 90% | Not verified | — |
| 5. Advisory vote to approve the compensation paid to the Company's named executive officers | 220,515,663 | 7,898,306 | 1,162,579 | -- | 51,246,117 | 97% | Not verified | — |
| 6. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2025 | 277,714,533 | 1,399,479 | 1,708,653 | -- | -- | 99.4% | Not verified | — |
Source: LEXICON PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 3, 2025 — read the filing on EDGAR.
Each item below shows how the 96 asset managers that disclosed a LEXICON PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LEXICON PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ivan H. Cheung
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ivan H. Cheung”): 226,232,365 for, 3,344,183 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,830,372 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 8,867 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 5,626 | 0 | 0 | 0 | For |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 1,855 | 0 | 0 | 0 | For |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Raymond Debbane
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Raymond Debbane”): 205,200,038 for, 24,376,510 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 2,222,977 for, 5,484,813 withheld, 122,582 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 13,299 | 0 | 0 | 5,108,014 | Withhold |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 304,767 | Withhold |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 81,250 | 0 | Abstain |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 55,662 | Withhold |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 41,332 | 0 | Abstain |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 8,867 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 5,626 | Withhold |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 1,855 | Withhold |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
90% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF AN AMENDMENT TO THE COMPANY'S SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT, AT THE DISCRETION OF THE COMPANY'S BOARD OF DIRECTORS, A REVERSE SPLIT OF ITS COMMON STOCK, AT A RATIO WITHIN A RANGE OF 1-FOR-10 TO 1-FOR-50, AT ANY TIME PRIOR TO THE COMPANY'S 2026 ANNUAL MEETING OF STOCKHOLDERS AND WITH THE ACTUAL RATIO TO BE DETERMINED WITHIN THAT RANGE AT THE DISCRETION OF THE COMPANY'S BOARD OF DIRECTORS
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“4. Approval of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's board of directors, a reverse split of its common stock, at a ratio withi”): 252,035,936 for, 28,448,014 against, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,830,372 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 8,867 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 5,626 | 0 | 0 | 0 | For |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 1,855 | 0 | 0 | 0 | For |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
94% of fund votes cast · no official result
Description as filed by funds: RATIFICATION AND APPROVAL OF THE AMENDMENT TO THE COMPANY'S 2017 EQUITY INCENTIVE PLAN
The 28 asset managers below reported 7,325,413 for, 504,959 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 436,672 | 0 | 0 | Against |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 0 | 19,421 | 0 | 0 | Against |
| DWS | 0 | 18,275 | 0 | 0 | Against |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 12,648 | 0 | 0 | Against |
| Calvert | 0 | 8,867 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 5,626 | 0 | 0 | Against |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 1,855 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 1,454 | 0 | 0 | Against |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 922 | 0 | 0 | Against |
| T. Rowe Price | 0 | 489 | 0 | 0 | Against |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
99.8% of fund votes cast · no official result
Description as filed by funds: RATIFICATION AND APPROVAL OF THE AMENDMENT TO THE COMPANY'S 2017 NON-EMPLOYEE DIRECTORS' EQUITY INCENTIVE PLAN
The 28 asset managers below reported 7,821,505 for, 8,867 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 0 | 8,867 | 0 | 0 | Against |
| Columbia Threadneedle | 5,626 | 0 | 0 | 0 | For |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 1,855 | 0 | 0 | 0 | For |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“5. Advisory vote to approve the compensation paid to the Company's named executive officers”): 220,515,663 for, 7,898,306 against, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 0 | 8,867 | 0 | 0 | Against |
| Columbia Threadneedle | 5,626 | 0 | 0 | 0 | For |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,855 | 0 | 0 | Against |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Fund voting reports, all 28 managers: 7,819,650 for, 10,722 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Artal Group S.A. | 136,180,481 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 38,918,903 | 0 | 0 | 0 | For |
| Fidelity | 18,792,079 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 2,200,000 | 0 | 0 | 0 | For |
| BlackRock | 1,410,527 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| State Street | 1,132,928 | 3,368 | 0 | 0 | For |
| BBR PARTNERS, LLC | 680,000 | 0 | 0 | 0 | For |
| Northern Trust | 525,529 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 403,458 | 0 | 0 | 0 | For |
| AllianceBernstein | 246,121 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 173,729 | 0 | 0 | 0 | For |
| Vanguard | 171,771 | 0 | 0 | 0 | For |
| BANK OF MONTREAL /CAN/ | 100,000 | 0 | 0 | 0 | For |
| AQR | 82,883 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 73,000 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 60,197 | 0 | 0 | 0 | For |
| Goldman Sachs | 55,130 | 0 | 0 | 0 | For |
| JPMorgan | 54,297 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 50,815 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 33,702 | 0 | 0 | 0 | For |
| Rhumbline | 31,117 | 60 | 0 | 0 | For |
| Invesco | 0 | 22,114 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 20,268 | 0 | 0 | 0 | For |
| Ethic Inc. | 0 | 17,259 | 0 | 0 | Against |
Institutional-manager reports, all 80 managers: 202,715,144 for, 78,746 against. Showing the 25 largest; every one is in the interactive database (link above).
99.4% Majority: yes · of votes cast
Description as filed by funds: RATIFICATION AND APPROVAL OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“6. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2025”): 277,714,533 for, 1,399,479 against, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 7,830,372 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,121,313 | 0 | 0 | 0 | For |
| Charles Schwab | 1,149,875 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 436,672 | 0 | 0 | 0 | For |
| Vanguard | 337,081 | 0 | 0 | 0 | For |
| Equitable | 304,767 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,016 | 0 | 0 | 0 | For |
| BlackRock | 81,250 | 0 | 0 | 0 | For |
| Global X | 68,683 | 0 | 0 | 0 | For |
| Pacific Life | 55,662 | 0 | 0 | 0 | For |
| Northern Trust | 44,158 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 41,332 | 0 | 0 | 0 | For |
| ProShares | 19,421 | 0 | 0 | 0 | For |
| DWS | 18,275 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,648 | 0 | 0 | 0 | For |
| Calvert | 8,867 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 5,626 | 0 | 0 | 0 | For |
| State Street | 5,012 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,560 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,353 | 0 | 0 | 0 | For |
| Invesco | 1,855 | 0 | 0 | 0 | For |
| Guggenheim | 1,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,369 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 922 | 0 | 0 | 0 | For |
| T. Rowe Price | 489 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 363,178,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 1.41% |
| 2 | Charles Schwab | 0.32% |
| 3 | ETFis Series Trust I | 0.12% |
| 4 | Vanguard | 0.09% |
| 5 | Equitable | 0.08% |
| 6 | Lincoln Financial | 0.03% |
| 7 | BlackRock | 0.02% |
| 8 | Global X | 0.02% |
| 9 | Pacific Life | 0.02% |
| 10 | Northern Trust | 0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Artal Group S.A. | 37.50% |
| 2 | Siren, L.L.C. | 10.72% |
| 3 | Fidelity | 5.17% |
| 4 | CIBC Private Wealth Group LLC | 0.61% |
| 5 | BlackRock | 0.39% |
| 6 | Charles Schwab | 0.32% |
| 7 | State Street | 0.31% |
| 8 | BBR PARTNERS, LLC | 0.19% |
| 9 | Northern Trust | 0.14% |
| 10 | PNC BANK, NATIONAL ASSOCIATION | 0.11% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Invus, L.P., Invus Public Equities, L.P., Invus US Partners, LLC and Artal Participations | — | DEF14A |
| Artal Participations S.a r.l. | — | 13D |
| Raymond Debbane | — | DEF14A |
| FMR LLC | — | 13G |
| FMR (Fidelity) | — | 13F |
| BlackRock | — | 13F |
| Vanguard Group | — | 13F |
| Geode Capital | — | 13F |
| State Street | — | 13F |
| AQR Capital | — | 13F |
Percentages above are of 363,178,000 shares outstanding, as reported by LEXICON PHARMACEUTICALS INC. on its Form 10-Q dated May 9, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LEXICON PHARMACEUTICALS INC.’s 10-Q dated May 9, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
LEXICON PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “LEXICON PHARMACEUTICALS (LXRX) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/lexicon-pharmaceuticals-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.